semaglutide drug shortage US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list

On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding

25.68

★★★★☆4.8 (126)

Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s

20.13

★★★★★4.9 (98)

Ozempic shortage: Diabetes patients at risk as TikTok and telehealth prescriptions fuel drug demand

20.70

★★★★★5.0 (157)

The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made

26.12

★★★★★4.7 (84)

The FDA Removes Semaglutide from the Drug Shortage List https://www.birminghammedicalnews.com/article/9195/the-fda-removes- semaglutide-from-the-drug-shortage-list #birminghammedicalnews #healthcarenews #wellness #healthcare Burr & Forman #hospital

26.15

★★★★★4.9 (203)

Novo Nordisk's semaglutide shortage officially concludes in the US, spelling major threat for weight loss drug compounders

24.05

★★★★★5.0 (176)

As GLP-1 Drug Shortage Ends, Why Will Patients Pay More?

22.07

★★★★★4.8 (132)